148 related articles for article (PubMed ID: 23154206)
1. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.
Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC
J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206
[TBL] [Abstract][Full Text] [Related]
2. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence.
Routh JC; Ashley RA; Sebo TJ; Lohse CM; Husmann DA; Kramer SA; Kwon ED
J Urol; 2008 May; 179(5):1954-9; discussion 1959-60. PubMed ID: 18355839
[TBL] [Abstract][Full Text] [Related]
3. p53 immunopositivity in histologically favorable Wilms tumor is not related to stage at presentation or to biological aggression.
D'Angelo MF; Kausik SJ; Sebo TJ; Rathbun SR; Kramer SA; Husmann DA
J Urol; 2003 May; 169(5):1815-7. PubMed ID: 12686851
[TBL] [Abstract][Full Text] [Related]
4. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
[TBL] [Abstract][Full Text] [Related]
6. p53 Immunohistochemistry expression in Wilms tumor: a prognostic tool in the detection of tumor aggressiveness.
Franken J; Lerut E; Van Poppel H; Bogaert G
J Urol; 2013 Feb; 189(2):664-70. PubMed ID: 23036984
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
[TBL] [Abstract][Full Text] [Related]
8. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
[TBL] [Abstract][Full Text] [Related]
9. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein expression, tumor weight, age, and relapse in patients with stage I and II favorable-histology Wilms' tumor.
Teixeira RA; Odone-Filho V; de Camargo B; Zerbini MC; Fillipi R; Alencar A; Cristofani L
Pediatr Hematol Oncol; 2011 Apr; 28(3):194-202. PubMed ID: 21214406
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
Suita S; Kinoshita Y; Tajiri T; Hara T; Tsuneyoshi M; Mizote H; Inada H; Takamatsu H; Kawano Y; Inomata Y; Nagasaki A; Ono Y; Handa N; Okamura J; Ishii E; Kawakami K;
J Pediatr Surg; 2006 Sep; 41(9):1501-5. PubMed ID: 16952581
[TBL] [Abstract][Full Text] [Related]
13. The treatment of Wilms tumor. Results of the National Wilms Tumor Studies.
Green DM; Thomas PR; Shochat S
Hematol Oncol Clin North Am; 1995 Dec; 9(6):1267-74. PubMed ID: 8591964
[TBL] [Abstract][Full Text] [Related]
14. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
[TBL] [Abstract][Full Text] [Related]
15. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
[TBL] [Abstract][Full Text] [Related]
16. Current therapy for Wilms' tumor.
Metzger ML; Dome JS
Oncologist; 2005; 10(10):815-26. PubMed ID: 16314292
[TBL] [Abstract][Full Text] [Related]
17. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
[TBL] [Abstract][Full Text] [Related]
18. Increased microvascular density predicts relapse in Wilms' tumor.
Abramson LP; Grundy PE; Rademaker AW; Helenowski I; Cornwell M; Katzenstein HM; Reynolds M; Arensman RM; Crawford SE
J Pediatr Surg; 2003 Mar; 38(3):325-30; discussion 325-30. PubMed ID: 12632343
[TBL] [Abstract][Full Text] [Related]
19. The feasibility and outcome of nephron-sparing surgery for children with bilateral Wilms tumor. The St Jude Children's Research Hospital experience: 1999-2006.
Davidoff AM; Giel DW; Jones DP; Jenkins JJ; Krasin MJ; Hoffer FA; Williams MA; Dome JS
Cancer; 2008 May; 112(9):2060-70. PubMed ID: 18361398
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biologic significance of nuclear unrest in Wilms tumor.
Hill DA; Shear TD; Liu T; Billups CA; Singh PK; Dome JS
Cancer; 2003 May; 97(9):2318-26. PubMed ID: 12712489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
